Author_Institution :
Sch. of Manage., Lanzhou Univ., Lanzhou, China
Abstract :
Taken 37 bio-pharmaceutical companies on SME board in China, this papers constructs a growth evaluation indicator system for these companies by operating income growth rate, net profits, sales net profit, returns on total asset, ROE, debt to equity, current ratio, working capital ratio, turnover of current asset, and turnover of total asset. By way of factor analysis, this empirical analysis on the growth can be of reference, for stakeholders, to make sound high-growth decisions.
Keywords :
pharmaceutical industry; profitability; small-to-medium enterprises; China; ROE; SME board; bio-pharmaceutical companies; debt to equity; growth evaluation indicator system; income growth rate; net profits; returns on total asset; sales net profit; Joints; Optimization; Competitiveness; Factor Analysis; Growth of Listed company; SME board; bio-pharmaceutical companies;
